Skip to content
The Nexus
HEALTHJun 29 · 20:00 UTCMEDPAGE TODAY

Loss of Payment Assistance for AMD Drugs Strains Patients and Ophthalmologists

Loss of copayment assistance for drugs treating neovascular age-related macular degeneration (nAMD) disrupted patient care, leading to shifts in therapy and reliance on samples. Patients and ophthalmologists face challenges due to the financial strain.

Nexus surfaces and summarizes. The full story lives at the source.

Mentioned
neovascular age-related macular degenerationtopicAMDtopicophthalmologistspersoncopayment assistancetopicsamplestopic
Spot something wrong with this article?Report a problem →
Forward this
Related Signal

Adjacent reporting